剖宫产术中皮下组织缝合与术后伤口并发症:系统评价与Meta分析
本系统评价与Meta分析纳入8项随机对照试验共1854例剖宫产患者(缝合组918例,非缝合组936例),评估皮下组织缝合对比非缝合对术后伤口并发症的影响。结果显示两组在手术部位感染、伤口裂开、血清肿、血肿及复合伤口结局方面均无显著差异,研究异质性低(I²<45%)。结论认为对所有患者常规实施皮下组织缝合不能显著降低伤口并发症风险。
要点
- 皮下组织缝合与非缝合相比,手术部位感染风险无显著差异(RR 0.95,95%CI 0.69-1.31)。
- 伤口裂开、血清肿、血肿及复合伤口结局在两组间均无显著差异。
- 研究异质性低(I²<45%),结论不支持对所有皮下厚度小于2 cm的患者常规缝合。
核心结论
- 剖宫产术中皮下组织缝合在普遍应用时不能显著降低伤口并发症风险。
- 这些发现不支持对所有皮下厚度小于2 cm的患者常规实施皮下组织缝合。
- 进一步研究应集中于完善患者选择标准并评估其他潜在获益,包括长期美容效果。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、EMBASE、Web of Science、Medline、Scopus、Cochrane Central Register of Clinical Trials及ClinicalTrials.gov从建库至2024年10月的随机对照试验。
- 纳入比较剖宫产术中皮下组织缝合与非缝合的随机对照试验,排除仅关注特定亚群(如皮下脂肪大于2 cm或肥胖)的研究。
- 共纳入8项试验,1854例参与者(缝合组918例,非缝合组936例)。
- 采用随机效应模型计算相对危险度(RR),使用I²统计量评估异质性。
主要发现
- 手术部位感染:缝合组 vs 非缝合组 RR 0.95(95%CI 0.69-1.31),无显著差异。
- 伤口裂开:缝合组 vs 非缝合组 RR 0.64(95%CI 0.21-1.98),无显著差异。
- 血清肿:缝合组 vs 非缝合组 RR 0.87(95%CI 0.05-14.81),无显著差异。
- 血肿:缝合组 vs 非缝合组 RR 0.54(95%CI 0.02-15.90),无显著差异。
- 复合伤口结局:缝合组 vs 非缝合组 RR 1.05(95%CI 0.80-1.38),无显著差异;研究异质性低(I²<45%)。
临床怎么用
- 原文结论指出,剖宫产术中皮下组织缝合在普遍应用时不能显著降低伤口并发症风险。
- 原文结论指出,这些发现不支持对所有皮下厚度小于2 cm的患者常规实施皮下组织缝合。
- 原文结论建议进一步研究应集中于完善患者选择标准并评估其他潜在获益,包括长期美容效果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The benefit of subcutaneous tissue closure during cesarean delivery (CD) has been well established in pregnant individuals with a subcutaneous tissue thickness greater than 2 cm. However, its routine application in all pregnant individuals remains a contentious topic. This meta-analysis aimed to evaluate and quantify the effect of subcutaneous tissue closure compared to nonclosure on postoperative wound complications in all patients undergoing CD. DATA SOURCES: We searched PubMed, EMBASE, Web of Science, Medline, Scopus, Cochrane Central Register of Clinical Trials, and ClinicalTrials.gov from their inception to October 2024 for randomized controlled trials (RCTs). STUDY ELIGIBILITY CRITERIA: Eligible studies included RCTs comparing subcutaneous tissue closure vs nonclosure in patients undergoing CD. Studies were excluded if they focused solely on selected subpopulations, such as pregnant individuals with subcutaneous fat >2 cm or those classified as obese. Primary outcomes were seroma formation, hematoma, surgical site infection (SSI), and wound dehiscence. Secondary outcomes included postoperative pain and cosmetic results. STUDY APPRAISAL AND SYNTHESIS METHODS: Random-effects models were used to calculate relative risks (RR) for each outcome. Heterogeneity across studies was assessed using the I² statistic. RESULTS: Eight trials comprising 1854 participants (918 closure, 936 nonclosure) met inclusion criteria. There were no significant differences between groups for SSI (RR 0.95, 95% CI: [0.69-1.31]), dehiscence (RR 0.64, 95% CI: [0.21-1.98]), seroma (RR 0.87, 95% CI: [0.05-14.81]), hematoma (RR 0.54, 95% CI: [0.02-15.90]), or composite wound outcomes (RR 1.05, 95% CI: [0.80-1.38]). Study heterogeneity was low (I²<45%). CONCLUSIONS: Subcutaneous tissue closure during CD does not significantly reduce the risk of wound complications when applied universally. These findings do not support its routine implementation for all patients with subcutaneous thickness less than 2 cm. Further research should focus on refining patient selection criteria and evaluating other potential benefits, including long-term cosmetic outcomes. El resumen está disponible en Español al final del artículo.
引用
- Bonanni G, Nguyen V, Francescutti M, et al. Subcutaneous tissue closure and postoperative wound complications in cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2025. PMID: 40541861. doi:10.1016/j.ajogmf.2025.101724
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。